Health Condition 1: B49- Unspecified mycosis
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: 1. ICU/Hospitalized patients of any age and gender with invasive fungal infections confirmed by culture, histopathology, microscopy or DNA evidence, as per the EORTC/MSG criteria, 2019 and Blot criteria 2012,19 (only proven and probable IFI cases) 2. All hospitalised cases of Mycetoma and chromoblastomycosis
Exclusion criteria
Exclusion criteria: 1. OPD patients 2. Possible cases and patients without evidence of invasive disease or those with colonisation only are not eligible. 3. Patients with superficial infections, and allergic fungal diseases like allergic bronchopulmonary aspergillosis will not be included. 4. Infection limited to the skin only will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital-based prevalence of invasive fungal infectionsTimepoint: Period which may be needed for initiating the Registry database and CRF: three months. Period which may be needed for collecting the data: Continuously from three months onwards Period that may be required for analyzing the data: Continuously from six months onwards. | — |
Secondary
| Measure | Time frame |
|---|---|
| Identifying risk factors of invasive fungal infections among ICU patientsTimepoint: Period which may be needed for initiating the Registry database and CRF: three months. Period which may be needed for collecting the data: Continuously from three months onwards Period that may be required for analyzing the data: Continuously from six months onwards. | — |
Countries
India
Contacts
Public ContactDr Khangembam Jitenkumar Singh
Indian Council of Medical Research
Outcome results
None listed